FAN, B.; WANG, M. Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report. Acta Dermato-Venereologica, [S. l.], v. 102, p. adv00732, 2022. DOI: 10.2340/actadv.v102.1378. Disponível em: https://medicaljournalssweden.se/actadv/article/view/1378. Acesso em: 29 mar. 2024.